$329 Thousand is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Buy | BIOGEN INC | $49,246 | +0.5% | 177,126 | +0.1% | 14.96% | -1.2% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $48,880 | +12.7% | 59,488 | -1.0% | 14.84% | +10.8% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $45,265 | -15.2% | 202,110 | +5.2% | 13.75% | -16.7% |
| EXEL | Sell | EXELIXIS INC | $41,457 | +20.9% | 2,135,868 | -0.1% | 12.59% | +18.8% |
| ALKS | Sell | ALKERMES PLC | $39,348 | +7.4% | 1,395,797 | -0.4% | 11.95% | +5.6% |
| Buy | EMBECTA CORP | $29,867 | +16.0% | 1,062,123 | +4.4% | 9.07% | +14.1% | |
| CAH | Buy | CARDINAL HEALTH INC | $26,672 | +4.3% | 353,278 | +6.2% | 8.10% | +2.5% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $24,397 | -11.8% | 603,301 | +1.4% | 7.41% | -13.3% |
| TARO | Sell | TARO PHARMACEUTICAL INDUS | $15,611 | -16.6% | 641,910 | -0.4% | 4.74% | -18.0% |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $3,227 | -3.8% | 113,737 | -0.9% | 0.98% | -5.5% |
| KOD | Sell | KODIAK SCIENCES INC | $2,849 | -14.2% | 459,489 | -0.9% | 0.86% | -15.7% |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $2,455 | -3.8% | 361,560 | +4.7% | 0.75% | -5.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.